Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Maze Therapeutics, Inc.

NASDAQ: MAZE · Life Sciences · 8 alerts · CIK 1842295

Share price
$33.90Close, Nov 16
Market cap
$1.85B
Shares outstanding
54.68MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Maze Therapeutics, Inc. filings on SEC EDGAR ↗

4:14 PM ET Form 4
Insider Selling

Maze Therapeutics CEO Jason V. Coloma Sells $1.04M of Stock

Jason V. Coloma, CEO, sold 34,501 shares of Maze Therapeutics, Inc. at $30.09 to $31.05 a share (average $30.25) in 4 transactions, worth $1.04M in total on Nov 2, 2026. Shares held after the trade: 186,901 (-2.8%).

Value
$1.04M
Shares
34,501
Average price
$30.25
Role
CEO
Holding change
-2.8%
Trade date
Nov 2, 2026
4:15 PM ET Form 4
Insider Selling

Maze Therapeutics Csbo Atul Dandekar Sells $241K of Stock

Atul Dandekar, Csbo, sold 7,500 shares of Maze Therapeutics, Inc. at $32.07 a share, worth $241K in total on Oct 29, 2026. Shares held after the trade: 32,316 (-18.8%).

Value
$241K
Shares
7,500
Price
$32.07
Role
Csbo
Holding change
-18.8%
Trade date
Oct 29, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.